Activist investor blasts Novavax for not using mRNA fears to boost sales of it COVID-19 vaccineQuartz • 8 days ago
The activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns some people have about mRNA vaccines to boost sales of its own traditional, protein-based COVID-19...
Share to Feed
In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, expressed disappointment with the recent performance of Novavax stock and...
CDC Study Doesn't 'Debunk' Link Between COVID-19 Vaccines & Sudden-Deaths
Authored by Zachary Stieber via The Epoch Times,
A new U.S. Centers for Disease Control and Prevention (CDC...
CDC Hid Finding Of Possible Link Between COVID Vaccines and Tinnitus
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
The U.S. Centers for Disease Control and Prevention...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024 Novavax Presents Data on Updated COVID-19...
It has been about a month since the last earnings report for Novavax (NVAX). Shares have lost about 3.2% in that time frame, underperforming the S&P 500.Will the recent negative trend continue...
Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX). T...
Investors in Novavax, Inc. (NVAX) saw new options become available today, for the May 10th expiration...
Investors in Novavax, Inc. (NVAX) saw new options become available today, for the May 3rd expiration...